Cancer Center Amsterdam
-
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
Haaksma, L. H., Palmieri, R., Reuvekamp, T., Tettero, J. M., Ngai, L. L., Bachas, C., Kelder, A., Scholten, W. J., Gradowska, P., Arena, V., João Simione, A., Maurillo, L., Venditti, A., Löwenberg, B., Ossenkoppele, G. J., de Leeuw, D. C., Ikoma-Colturato, M. R. V., Buccisano, F. & Cloos, J., 10 Dec 2025, (E-pub ahead of print) In: Leukemia.Research output: Contribution to journal › Article › Academic › peer-review
-
Measurable residual disease monitoring in acute myeloid leukaemia: Techniques, timing and therapeutic implications
Croese, K. J., Cloos, J. & Tettero, J. M., Jun 2025, In: Seminars in Hematology. 62, 3, p. 167-176 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Venditti, A., Palmieri, R., Maurillo, L., Röllig, C., Wierzbowska, A., de Leeuw, D., Efficace, F., Curti, A., Lam Ngai, L., Tettero, J., Adès, L., Almeida, A., Bullinger, L., Dennis, M., Esteve, J., Ferrara, F., Heuser, M., Huls, G., Lübbert, M. & Mehta, P. & 13 others, , 13 May 2025, In: Blood. 9, 9, p. 2207-2220 14 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications